{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:33:43Z","timestamp":1790703223728,"version":"4.1.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107660\/Z\/15Z"],"award-info":[{"award-number":["107660\/Z\/15Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Colonization by the microbiota provides one of our most effective barriers against infection by pathogenic microbes. The microbiota protects against infection by priming immune defenses, by metabolic exclusion of pathogens from their preferred niches, and through direct antimicrobial antagonism. Disruption of the microbiota, especially by antibiotics, is a major risk factor for bacterial pathogen colonization. Restoration of the microbiota through microbiota transplantation has been shown to be an effective way to reduce pathogen burden in the intestine but comes with a number of drawbacks, including the possibility of transferring other pathogens into the host, lack of standardization, and potential disruption to host metabolism. More refined methods to exploit the power of the microbiota would allow us to utilize its protective power without the drawbacks of fecal microbiota transplantation. To achieve this requires detailed understanding of which members of the microbiota protect against specific pathogens and the mechanistic basis for their effects. In this review, we will discuss the clinical and experimental evidence that has begun to reveal which members of the microbiota protect against some of the most troublesome antibiotic-resistant pathogens:\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    , vancomycin-resistant enterococci, and\n                    <jats:italic>Clostridioides difficile<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41435-021-00129-5","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T05:03:59Z","timestamp":1620104639000},"page":"255-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Microbiota-mediated protection against antibiotic-resistant pathogens"],"prefix":"10.1038","volume":"22","author":[{"given":"Rekha B.","family":"Panwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9997-9532","authenticated-orcid":false,"given":"Thomas B.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"129_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","volume":"124","author":"RE Ley","year":"2006","unstructured":"Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837\u201348.","journal-title":"Cell."},{"key":"129_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrg3182","volume":"13","author":"I Cho","year":"2012","unstructured":"Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13:260\u201370.","journal-title":"Nat Rev Genet"},{"key":"129_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature18849","volume":"535","author":"AJ Baumler","year":"2016","unstructured":"Baumler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535:85\u201393.","journal-title":"Nature."},{"key":"129_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-020711-074937","volume":"30","author":"K Honda","year":"2012","unstructured":"Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol. 2012;30:759\u201395.","journal-title":"Annu Rev Immunol"},{"key":"129_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12634","volume":"150","author":"RL Brown","year":"2017","unstructured":"Brown RL, Clarke TB. The regulation of host defences to infection by the microbiota. Immunology. 2017;150:1\u20136.","journal-title":"Immunology."},{"key":"129_CR6","doi-asserted-by":"publisher","first-page":"e1004506","DOI":"10.1371\/journal.ppat.1004506","volume":"10","author":"TB Clarke","year":"2014","unstructured":"Clarke TB. Microbial programming of systemic innate immunity and resistance to infection. PLoS Pathog. 2014;10:e1004506.","journal-title":"PLoS Pathog"},{"key":"129_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121\u201341.","journal-title":"Cell."},{"key":"129_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-065X.2011.01084.x","volume":"245","author":"D Mathis","year":"2012","unstructured":"Mathis D, Benoist C. The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol Rev. 2012;245:239\u201349.","journal-title":"Immunol Rev"},{"key":"129_CR9","doi-asserted-by":"publisher","first-page":"11548","DOI":"10.1073\/pnas.1108924108","volume":"108","author":"MA Kriegel","year":"2011","unstructured":"Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA. 2011;108:11548\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"129_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/embj.201489966","volume":"34","author":"JT Van Praet","year":"2015","unstructured":"Van Praet JT, Donovan E, Vanassche I, Drennan MB, Windels F, Dendooven A, et al. Commensal microbiota influence systemic autoimmune responses. EMBO J. 2015;34:466\u201374.","journal-title":"EMBO J"},{"key":"129_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.chom.2017.04.002","volume":"21","author":"S Caballero","year":"2017","unstructured":"Caballero S, Kim S, Carter RA, Leiner IM, Susac B, Miller L, et al. Cooperating commensals restore colonization resistance to vancomycin-resistant Enterococcus faecium. Cell Host Microbe. 2017;21:592\u2013602. e4","journal-title":"Cell Host Microbe"},{"key":"129_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.chom.2017.05.005","volume":"21","author":"S Thiemann","year":"2017","unstructured":"Thiemann S, Smit N, Roy U, Lesker TR, Galvez EJC, Helmecke J, et al. Enhancement of IFNgamma production by distinct commensals Ameliorates Salmonella-induced disease. Cell Host Microbe. 2017;21:682\u201394. e5","journal-title":"Cell Host Microbe"},{"key":"129_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01803-x","volume":"8","author":"RL Brown","year":"2017","unstructured":"Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun. 2017;8:1512.","journal-title":"Nat Commun"},{"key":"129_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nm.2087","volume":"16","author":"TB Clarke","year":"2010","unstructured":"Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010;16:228\u201331.","journal-title":"Nat Med"},{"key":"129_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nm.3542","volume":"20","author":"HS Deshmukh","year":"2014","unstructured":"Deshmukh HS, Liu Y, Menkiti OR, Mei J, Dai N, O\u2019Leary CE, et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med. 2014;20:524\u201330.","journal-title":"Nat Med"},{"key":"129_CR16","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature05836","volume":"447","author":"SL Foster","year":"2007","unstructured":"Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007;447:972\u20138.","journal-title":"Nature."},{"key":"129_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41564-019-0640-1","volume":"5","author":"RP Sequeira","year":"2020","unstructured":"Sequeira RP, McDonald JAK, Marchesi JR, Clarke TB. Commensal Bacteroidetes protect against Klebsiella pneumoniae colonization and transmission through IL-36 signalling. Nat Microbiol. 2020;5:304\u201313.","journal-title":"Nat Microbiol"},{"key":"129_CR18","doi-asserted-by":"publisher","first-page":"11971","DOI":"10.1073\/pnas.1002601107","volume":"107","author":"MG Dominguez-Bello","year":"2010","unstructured":"Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107:11971\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"129_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1053\/j.gastro.2011.02.011","volume":"140","author":"MG Dominguez-Bello","year":"2011","unstructured":"Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology. 2011;140:1713\u20139.","journal-title":"Gastroenterology."},{"key":"129_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tree.2006.06.013","volume":"21","author":"L Dethlefsen","year":"2006","unstructured":"Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol. 2006;21:517\u201323.","journal-title":"Trends Ecol Evol"},{"key":"129_CR21","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1073\/pnas.1424886112","volume":"112","author":"S Rakoff-Nahoum","year":"2015","unstructured":"Rakoff-Nahoum S, Kong Y, Kleinstein SH, Subramanian S, Ahern PP, Gordon JI, et al. Analysis of gene-environment interactions in postnatal development of the mammalian intestine. Proc Natl Acad Sci USA. 2015;112:1929\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"129_CR22","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1371\/journal.pbio.0050177","volume":"5","author":"C Palmer","year":"2007","unstructured":"Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5:e177.","journal-title":"PLoS Biol"},{"key":"129_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.molmed.2014.12.002","volume":"21","author":"NT Mueller","year":"2015","unstructured":"Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med. 2015;21:109\u201317.","journal-title":"Trends Mol Med"},{"key":"129_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.chom.2018.06.005","volume":"24","author":"P Ferretti","year":"2018","unstructured":"Ferretti P, Pasolli E, Tett A, Asnicar F, Gorfer V, Fedi S, et al. Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome. Cell Host Microbe. 2018;24:133\u201345. e5","journal-title":"Cell Host Microbe"},{"key":"129_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-1560-1","volume":"574","author":"Y Shao","year":"2019","unstructured":"Shao Y, Forster SC, Tsaliki E, Vervier K, Strang A, Simpson N, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019;574:117\u201321.","journal-title":"Nature."},{"key":"129_CR26","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2020.01.024","volume":"158","author":"G Galazzo","year":"2020","unstructured":"Galazzo G, van Best N, Bervoets L, Dapaah IO, Savelkoul PH, Hornef MW, et al. Development of the microbiota and associations with birth mode, diet, and atopic disorders in a longitudinal analysis of stool samples, collected from infancy through early childhood. Gastroenterology. 2020;158:1584\u201396.","journal-title":"Gastroenterology."},{"key":"129_CR27","doi-asserted-by":"publisher","first-page":"eaax9929.","DOI":"10.1126\/scitranslmed.aax9929","volume":"12","author":"J Stokholm","year":"2020","unstructured":"Stokholm J, Thorsen J, Blaser MJ, Rasmussen MA, Hjelmso M, Shah S, et al. Delivery mode and gut microbial changes correlate with an increased risk of childhood asthma. Sci Transl Med. 2020;12:eaax9929.","journal-title":"Sci Transl Med"},{"key":"129_CR28","first-page":"26050","volume":"26","author":"JM Rodriguez","year":"2015","unstructured":"Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Micro Ecol Health Dis. 2015;26:26050.","journal-title":"Micro Ecol Health Dis"},{"key":"129_CR29","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1128\/AEM.00342-14","volume":"80","author":"A Bergstrom","year":"2014","unstructured":"Bergstrom A, Skov TH, Bahl MI, Roager HM, Christensen LB, Ejlerskov KT, et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol. 2014;80:2889\u2013900.","journal-title":"Appl Environ Microbiol"},{"key":"129_CR30","doi-asserted-by":"publisher","first-page":"20140294.","DOI":"10.1098\/rstb.2014.0294","volume":"370","author":"WA de Steenhuijsen Piters","year":"2015","unstructured":"de Steenhuijsen Piters WA, Sanders EA, Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc Lond B Biol Sci. 2015;370:20140294.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"129_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.chom.2018.10.019","volume":"24","author":"C Pattaroni","year":"2018","unstructured":"Pattaroni C, Watzenboeck ML, Schneidegger S, Kieser S, Wong NC, Bernasconi E, et al. Early-life formation of the microbial and immunological environment of the human airways. Cell Host Microbe. 2018;24:857\u201365. e4","journal-title":"Cell Host Microbe"},{"key":"129_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.aad9378","volume":"352","author":"T Gensollen","year":"2016","unstructured":"Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539\u201344.","journal-title":"Science"},{"key":"129_CR33","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268\u201373.","journal-title":"Science"},{"key":"129_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri.2017.54","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhivaki D, Lo-Man R. Unique aspects of the perinatal immune system. Nat Rev Immunol. 2017;17:495\u2013507.","journal-title":"Nat Rev Immunol"},{"key":"129_CR35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nri.2016.114","volume":"16","author":"JL Kubinak","year":"2016","unstructured":"Kubinak JL, Round JL. Do antibodies select a healthy microbiota? Nat Rev Immunol. 2016;16:767\u201374.","journal-title":"Nat Rev Immunol"},{"key":"129_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1126\/science.aad9382","volume":"352","author":"EG Pamer","year":"2016","unstructured":"Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016;352:535\u20138.","journal-title":"Science."},{"key":"129_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJM200008033430506","volume":"343","author":"R Medzhitov","year":"2000","unstructured":"Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343:338\u201344.","journal-title":"N Engl J Med"},{"key":"129_CR38","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.jaci.2009.07.016","volume":"125","author":"SE Turvey","year":"2010","unstructured":"Turvey SE, Broide DH. Innate immunity. J Allergy Clin Immunol. 2010;125:S24\u201332.","journal-title":"J Allergy Clin Immunol"},{"key":"129_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan C. Points of control in inflammation. Nature. 2002;420:846\u201352.","journal-title":"Nature."},{"key":"129_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.aba0478","volume":"368","author":"SC Ganal-Vonarburg","year":"2020","unstructured":"Ganal-Vonarburg SC, Hornef MW, Macpherson AJ. Microbial-host molecular exchange and its functional consequences in early mammalian life. Science. 2020;368:604\u20137.","journal-title":"Science"},{"key":"129_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1600-065X.2008.00713.x","volume":"226","author":"SA Saenz","year":"2008","unstructured":"Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev. 2008;226:172\u201390.","journal-title":"Immunol Rev"},{"key":"129_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.smim.2011.11.002","volume":"24","author":"CU Duerr","year":"2012","unstructured":"Duerr CU, Hornef MW. The mammalian intestinal epithelium as integral player in the establishment and maintenance of host-microbial homeostasis. Semin Immunol. 2012;24:25\u201335.","journal-title":"Semin Immunol"},{"key":"129_CR43","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07250","volume":"455","author":"K Brandl","year":"2008","unstructured":"Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008;455:804\u20137.","journal-title":"Nature."},{"key":"129_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrmicro3552","volume":"14","author":"GP Donaldson","year":"2016","unstructured":"Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016;14:20\u201332.","journal-title":"Nat Rev Microbiol"},{"key":"129_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.chom.2010.09.005","volume":"8","author":"C Chassin","year":"2010","unstructured":"Chassin C, Kocur M, Pott J, Duerr CU, Gutle D, Lotz M, et al. miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host Microbe. 2010;8:358\u201368.","journal-title":"Cell Host Microbe"},{"key":"129_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/00005176-200104000-00011","volume":"32","author":"S Naik","year":"2001","unstructured":"Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr. 2001;32:449\u201353.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"129_CR47","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1128\/AEM.03021-10","volume":"77","author":"G Kaci","year":"2011","unstructured":"Kaci G, Lakhdari O, Dore J, Ehrlich SD, Renault P, Blottiere HM, et al. Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl Environ Microbiol. 2011;77:4681\u20134.","journal-title":"Appl Environ Microbiol"},{"key":"129_CR48","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.freeradbiomed.2009.07.033","volume":"47","author":"PW Lin","year":"2009","unstructured":"Lin PW, Myers LE, Ray L, Song SC, Nasr TR, Berardinelli AJ, et al. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med. 2009;47:1205\u201311.","journal-title":"Free Radic Biol Med"},{"key":"129_CR49","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4049\/jimmunol.176.2.1228","volume":"176","author":"MT Tien","year":"2006","unstructured":"Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppee JY, et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol. 2006;176:1228\u201337.","journal-title":"J Immunol"},{"key":"129_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/imm.12159","volume":"140","author":"D Karmarkar","year":"2013","unstructured":"Karmarkar D, Rock KL. Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response. Immunology. 2013;140:483\u201392.","journal-title":"Immunology."},{"key":"129_CR51","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1182\/blood-2015-10-675173","volume":"127","author":"CB Hergott","year":"2016","unstructured":"Hergott CB, Roche AM, Tamashiro E, Clarke TB, Bailey AG, Laughlin A, et al. Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis. Blood. 2016;127:2460\u201371.","journal-title":"Blood."},{"key":"129_CR52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445\u201355.","journal-title":"Nature."},{"key":"129_CR53","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.1178331","volume":"327","author":"F Geissmann","year":"2010","unstructured":"Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327:656\u201361.","journal-title":"Science."},{"key":"129_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/mi.2010.66","volume":"4","author":"PD Smith","year":"2011","unstructured":"Smith PD, Smythies LE, Shen R, Greenwell-Wild T, Gliozzi M, Wahl SM. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol. 2011;4:31\u201342.","journal-title":"Mucosal Immunol"},{"key":"129_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri3600","volume":"14","author":"T Hussell","year":"2014","unstructured":"Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol. 2014;14:81\u201393.","journal-title":"Nat Rev Immunol"},{"key":"129_CR56","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni.2967","volume":"15","author":"CC Bain","year":"2014","unstructured":"Bain CC, Bravo-Blas A, Scott CL, Perdiguero EG, Geissmann F, Henri S, et al. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat Immunol. 2014;15:929\u201337.","journal-title":"Nat Immunol"},{"key":"129_CR57","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111:2247\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"129_CR58","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"50","author":"J Schulthess","year":"2019","unstructured":"Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity. 2019;50:432\u201345. e7","journal-title":"Immunity."},{"key":"129_CR59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2012.05.020","volume":"37","author":"SC Ganal","year":"2012","unstructured":"Ganal SC, Sanos SL, Kallfass C, Oberle K, Johner C, Kirschning C, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity. 2012;37:171\u201386.","journal-title":"Immunity."},{"key":"129_CR60","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","volume":"37","author":"MC Abt","year":"2012","unstructured":"Abt MC, Osborne LC, Monticelli LA, Doering TA, Alenghat T, Sonnenberg GF, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity. 2012;37:158\u201370.","journal-title":"Immunity."},{"key":"129_CR61","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451\u20135.","journal-title":"Nature."},{"key":"129_CR62","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chom.2012.08.004","volume":"12","author":"Y Shen","year":"2012","unstructured":"Shen Y, Giardino Torchia ML, Lawson GW, Karp CL, Ashwell JD, Mazmanian SK. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe. 2012;12:509\u201320.","journal-title":"Cell Host Microbe"},{"key":"129_CR63","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1073\/pnas.1019378108","volume":"108","author":"T Ichinohe","year":"2011","unstructured":"Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA. 2011;108:5354\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"129_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1084\/jem.20150567","volume":"213","author":"D Ruane","year":"2016","unstructured":"Ruane D, Chorny A, Lee H, Faith J, Pandey G, Shan M, et al. Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses. J Exp Med. 2016;213:53\u201373.","journal-title":"J Exp Med"},{"key":"129_CR65","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nri.2016.75","volume":"16","author":"G Eberl","year":"2016","unstructured":"Eberl G. Immunity by equilibrium. Nat Rev Immunol. 2016;16:524\u201332.","journal-title":"Nat Rev Immunol"},{"key":"129_CR66","doi-asserted-by":"publisher","first-page":"ftw111.","DOI":"10.1093\/femspd\/ftw111","volume":"74","author":"M Valeri","year":"2016","unstructured":"Valeri M, Raffatellu M. Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis. 2016;74:ftw111.","journal-title":"Pathog Dis"},{"key":"129_CR67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2015.08.061","volume":"163","author":"T Sano","year":"2015","unstructured":"Sano T, Huang W, Hall JA, Yang Y, Chen A, Gavzy SJ, et al. An IL-23R\/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell. 2015;163:381\u201393.","journal-title":"Cell."},{"key":"129_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1084\/jem.20111703","volume":"209","author":"MH Shaw","year":"2012","unstructured":"Shaw MH, Kamada N, Kim YG, Nunez G. Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med. 2012;209:251\u20138.","journal-title":"J Exp Med"},{"key":"129_CR69","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485\u201398.","journal-title":"Cell"},{"key":"129_CR70","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature07240","volume":"455","author":"K Atarashi","year":"2008","unstructured":"Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, et al. ATP drives lamina propria T(H)17 cell differentiation. Nature. 2008;455:808\u201312.","journal-title":"Nature."},{"key":"129_CR71","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1084\/jem.20080034","volume":"205","author":"M Lochner","year":"2008","unstructured":"Lochner M, Peduto L, Cherrier M, Sawa S, Langa F, Varona R, et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med. 2008;205:1381\u201393.","journal-title":"J Exp Med"},{"key":"129_CR72","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531\u201364.","journal-title":"Annu Rev Immunol"},{"key":"129_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337\u201341.","journal-title":"Science."},{"key":"129_CR74","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12275-018-7565-x","volume":"56","author":"JH Park","year":"2018","unstructured":"Park JH, Eberl G. Type 3 regulatory T cells at the interface of symbiosis. J Microbiol. 2018;56:163\u201371.","journal-title":"J Microbiol"},{"key":"129_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12240","volume":"498","author":"MR Hepworth","year":"2013","unstructured":"Hepworth MR, Monticelli LA, Fung TC, Ziegler CG, Grunberg S, Sinha R, et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature. 2013;498:113\u20137.","journal-title":"Nature."},{"key":"129_CR76","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ni.2002","volume":"12","author":"S Sawa","year":"2011","unstructured":"Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Berard M, Kleinschek M, et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol. 2011;12:320\u20136.","journal-title":"Nat Immunol"},{"key":"129_CR77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ni.3332","volume":"17","author":"LC Rankin","year":"2016","unstructured":"Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat Immunol. 2016;17:179\u201386.","journal-title":"Nat Immunol"},{"key":"129_CR78","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2020.03.002","volume":"52","author":"N Satoh-Takayama","year":"2020","unstructured":"Satoh-Takayama N, Kato T, Motomura Y, Kageyama T, Taguchi-Atarashi N, Kinoshita-Daitoku R, et al. Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA. Immunity. 2020;52:635\u201349. e4","journal-title":"Immunity."},{"key":"129_CR79","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1126\/science.1243364","volume":"342","author":"AA Kruglov","year":"2013","unstructured":"Kruglov AA, Grivennikov SI, Kuprash DV, Winsauer C, Prepens S, Seleznik GM, et al. Nonredundant function of soluble LTalpha3 produced by innate lymphoid cells in intestinal homeostasis. Science. 2013;342:1243\u20136.","journal-title":"Science."},{"key":"129_CR80","doi-asserted-by":"publisher","first-page":"1249288","DOI":"10.1126\/science.1249288","volume":"343","author":"A Mortha","year":"2014","unstructured":"Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 2014;343:1249288.","journal-title":"Science."},{"key":"129_CR81","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1086\/422002","volume":"39","author":"CJ Donskey","year":"2004","unstructured":"Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis. 2004;39:219\u201326.","journal-title":"Clin Infect Dis"},{"key":"129_CR82","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.12563","volume":"279","author":"S Kim","year":"2017","unstructured":"Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017;279:90\u2013105.","journal-title":"Immunol Rev"},{"key":"129_CR83","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cid\/cix270","volume":"65","author":"CL Gorrie","year":"2017","unstructured":"Gorrie CL, Mirceta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65:208\u201315.","journal-title":"Clin Infect Dis"},{"key":"129_CR84","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1128\/CMR.11.4.589","volume":"11","author":"R Podschun","year":"1998","unstructured":"Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11:589\u2013603.","journal-title":"Clin Microbiol Rev"},{"key":"129_CR85","doi-asserted-by":"publisher","first-page":"e00261","DOI":"10.1128\/mSphere.00261-16","volume":"1","author":"RM Martin","year":"2016","unstructured":"Martin RM, Cao J, Brisse S, Passet V, Wu W, Zhao L. et al. Molecular epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae. mSphere. 2016;1:e00261\u201316.","journal-title":"mSphere"},{"key":"129_CR86","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1017\/S0195941700062603","volume":"6","author":"ST Bagley","year":"1985","unstructured":"Bagley ST. Habitat association of Klebsiella species. Infect Control. 1985;6:52\u20138.","journal-title":"Infect Control"},{"key":"129_CR87","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198\u2013208.","journal-title":"N Engl J Med"},{"key":"129_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcimb.2018.00004","volume":"8","author":"RM Martin","year":"2018","unstructured":"Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018;8:4.","journal-title":"Front Cell Infect Microbiol"},{"key":"129_CR89","doi-asserted-by":"publisher","first-page":"omz032","DOI":"10.1093\/omcr\/omz032","volume":"2019","author":"S Rodriguez-Villar","year":"2019","unstructured":"Rodriguez-Villar S, Fife A, Baldwin C, Warne RR. Antibiotic-resistant hypervirulent Klebsiella pneumoniae causing community- acquired liver abscess: an emerging disease. Oxf Med Case Rep. 2019;2019:omz032.","journal-title":"Oxf Med Case Rep."},{"key":"129_CR90","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/joim.13007","volume":"287","author":"JE Choby","year":"2020","unstructured":"Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae\u2014clinical and molecular perspectives. J Intern Med. 2020;287:283\u2013300.","journal-title":"J Intern Med"},{"key":"129_CR91","first-page":"165","volume":"62","author":"Centers for Disease Control and Prevention.","year":"2013","unstructured":"Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013;62:165\u201370.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"129_CR92","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhin.2017.08.012","volume":"97","author":"MC Salomao","year":"2017","unstructured":"Salomao MC, Guimaraes T, Duailibi DF, Perondi MBM, Letaif LSH, Montal AC, et al. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate. J Hosp Infect. 2017;97:241\u20136.","journal-title":"J Hosp Infect"},{"key":"129_CR93","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jhin.2009.07.022","volume":"74","author":"Y Wiener-Well","year":"2010","unstructured":"Wiener-Well Y, Rudensky B, Yinnon AM, Kopuit P, Schlesinger Y, Broide E, et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect. 2010;74:344\u20139.","journal-title":"J Hosp Infect"},{"key":"129_CR94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/ice.2015.254","volume":"37","author":"JP Mills","year":"2016","unstructured":"Mills JP, Talati NJ, Alby K, Han JH. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol. 2016;37:55\u201360.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"129_CR95","doi-asserted-by":"publisher","first-page":"114399","DOI":"10.1016\/j.envpol.2020.114399","volume":"265","author":"L Liu","year":"2020","unstructured":"Liu L, Wang Q, Wu X, Qi H, Das R, Lin H, et al. Vancomycin exposure caused opportunistic pathogens bloom in intestinal microbiome by simulator of the human intestinal microbial ecosystem (SHIME). Environ Pollut. 2020;265:114399.","journal-title":"Environ Pollut"},{"key":"129_CR96","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/cid\/cix252","volume":"65","author":"J Bilinski","year":"2017","unstructured":"Bilinski J, Grzesiowski P, Sorensen N, Madry K, Muszynski J, Robak K, et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study. Clin Infect Dis. 2017;65:364\u201370.","journal-title":"Clin Infect Dis"},{"key":"129_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3293-x","volume":"11","author":"R Singh","year":"2018","unstructured":"Singh R, de Groot PF, Geerlings SE, Hodiamont CJ, Belzer C, Berge I, et al. Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study. BMC Res Notes. 2018;11:190.","journal-title":"BMC Res Notes"},{"key":"129_CR98","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1084\/jem.20181639","volume":"216","author":"MT Sorbara","year":"2019","unstructured":"Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, et al. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2019;216:84\u201398.","journal-title":"J Exp Med"},{"key":"129_CR99","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1128\/JCM.37.1.56-62.1999","volume":"37","author":"DS Hansen","year":"1999","unstructured":"Hansen DS, Mestre F, Alberti S, Hernandez-Alles S, Alvarez D, Domenech-Sanchez A, et al. Klebsiella pneumoniae lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries. J Clin Microbiol. 1999;37:56\u201362.","journal-title":"J Clin Microbiol"},{"key":"129_CR100","first-page":"e000102","volume":"2","author":"KL Wyres","year":"2016","unstructured":"Wyres KL, Wick RR, Gorrie C, Jenney A, Follador R, Thomson NR, et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Micro Genom. 2016;2:e000102.","journal-title":"Micro Genom"},{"key":"129_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/srep29316","volume":"6","author":"IR Lee","year":"2016","unstructured":"Lee IR, Molton JS, Wyres KL, Gorrie C, Wong J, Hoh CH, et al. Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse population. Sci Rep. 2016;6:29316.","journal-title":"Sci Rep"},{"key":"129_CR102","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/gut.50.3.420","volume":"50","author":"CP Fung","year":"2002","unstructured":"Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut. 2002;50:420\u20134.","journal-title":"Gut."},{"key":"129_CR103","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1128\/JCM.01150-06","volume":"45","author":"KM Yeh","year":"2007","unstructured":"Yeh KM, Kurup A, Siu LK, Koh YL, Fung CP, Lin JC, et al. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol. 2007;45:466\u201371.","journal-title":"J Clin Microbiol"},{"key":"129_CR104","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1099\/mic.0.25833-0","volume":"149","author":"C Struve","year":"2003","unstructured":"Struve C, Forestier C, Krogfelt KA. Application of a novel multi-screening signature-tagged mutagenesis assay for identification of Klebsiella pneumoniae genes essential in colonization and infection. Microbiol (Read). 2003;149:167\u201376.","journal-title":"Microbiol (Read)"},{"key":"129_CR105","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1471-2180-12-201","volume":"12","author":"EJ Boll","year":"2012","unstructured":"Boll EJ, Nielsen LN, Krogfelt KA, Struve C. Novel screening assay for in vivo selection of Klebsiella pneumoniae genes promoting gastrointestinal colonisation. BMC Microbiol. 2012;12:201.","journal-title":"BMC Microbiol"},{"key":"129_CR106","doi-asserted-by":"publisher","first-page":"e02663","DOI":"10.1128\/mBio.02663-18","volume":"10","author":"HJ Jung","year":"2019","unstructured":"Jung HJ, Littmann ER, Seok R, Leiner IM, Taur Y, Peled J. et al. Genome-wide screening for enteric colonization factors in carbapenem-resistant ST258 Klebsiella pneumoniae. mBio. 2019;10:e02663\u201318.","journal-title":"mBio"},{"key":"129_CR107","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/mmi.14447","volume":"113","author":"YH Tan","year":"2020","unstructured":"Tan YH, Chen Y, Chu WHW, Sham LT, Gan YH. Cell envelope defects of different capsule-null mutants in K1 hypervirulent Klebsiella pneumoniae can affect bacterial pathogenesis. Mol Microbiol. 2020;113:889\u2013905.","journal-title":"Mol Microbiol"},{"key":"129_CR108","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1574-6968.2003.tb11511.x","volume":"218","author":"C Struve","year":"2003","unstructured":"Struve C, Krogfelt KA. Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between in vitro and in vivo studies. FEMS Microbiol Lett. 2003;218:149\u201354.","journal-title":"FEMS Microbiol Lett"},{"key":"129_CR109","doi-asserted-by":"publisher","first-page":"GPP3-0053-2018.","DOI":"10.1128\/microbiolspec.GPP3-0053-2018","volume":"7","author":"E Fiore","year":"2019","unstructured":"Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of enterococci. Microbiol Spectr. 2019;7:GPP3-0053-2018.","journal-title":"Microbiol Spectr"},{"key":"129_CR110","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-micro-091213-113003","volume":"68","author":"D Van Tyne","year":"2014","unstructured":"Van Tyne D, Gilmore MS. Friend turned foe: evolution of enterococcal virulence and antibiotic resistance. Annu Rev Microbiol. 2014;68:337\u201356.","journal-title":"Annu Rev Microbiol"},{"key":"129_CR111","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature11711","volume":"493","author":"S Schloissnig","year":"2013","unstructured":"Schloissnig S, Arumugam M, Sunagawa S, Mitreva M, Tap J, Zhu A, et al. Genomic variation landscape of the human gut microbiome. Nature. 2013;493:45\u201350.","journal-title":"Nature."},{"key":"129_CR112","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1128\/CMR.7.4.462","volume":"7","author":"BD Jett","year":"1994","unstructured":"Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev. 1994;7:462\u201378.","journal-title":"Clin Microbiol Rev"},{"key":"129_CR113","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/nature00802","volume":"417","author":"N Shankar","year":"2002","unstructured":"Shankar N, Baghdayan AS, Gilmore MS. Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature. 2002;417:746\u201350.","journal-title":"Nature."},{"key":"129_CR114","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1126\/science.1080613","volume":"299","author":"IT Paulsen","year":"2003","unstructured":"Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, et al. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 2003;299:2071\u20134.","journal-title":"Science."},{"key":"129_CR115","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/infdis\/jiv597","volume":"213","author":"MC Montealegre","year":"2016","unstructured":"Montealegre MC, Singh KV, Murray BE. Gastrointestinal tract colonization dynamics by different Enterococcus faecium clades. J Infect Dis. 2016;213:1914\u201322.","journal-title":"J Infect Dis"},{"key":"129_CR116","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","volume":"343","author":"CJ Donskey","year":"2000","unstructured":"Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343:1925\u201332.","journal-title":"N Engl J Med"},{"key":"129_CR117","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/IAI.01197-12","volume":"81","author":"C Ubeda","year":"2013","unstructured":"Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun. 2013;81:965\u201373.","journal-title":"Infect Immun"},{"key":"129_CR118","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.chom.2014.08.017","volume":"16","author":"TA Pham","year":"2014","unstructured":"Pham TA, Clare S, Goulding D, Arasteh JM, Stares MD, Browne HP, et al. Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe. 2014;16:504\u201316.","journal-title":"Cell Host Microbe"},{"key":"129_CR119","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41586-019-1501-z","volume":"572","author":"SG Kim","year":"2019","unstructured":"Kim SG, Becattini S, Moody TU, Shliaha PV, Littmann ER, Seok R, et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature. 2019;572:665\u20139.","journal-title":"Nature."},{"key":"129_CR120","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature15524","volume":"526","author":"S Kommineni","year":"2015","unstructured":"Kommineni S, Bretl DJ, Lam V, Chakraborty R, Hayward M, Simpson P, et al. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature. 2015;526:719\u201322.","journal-title":"Nature."},{"key":"129_CR121","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","volume":"372","author":"FC Lessa","year":"2015","unstructured":"Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825\u201334.","journal-title":"N Engl J Med"},{"key":"129_CR122","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","volume":"372","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372:1539\u201348.","journal-title":"N Engl J Med"},{"key":"129_CR123","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrmicro.2016.108","volume":"14","author":"MC Abt","year":"2016","unstructured":"Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016;14:609\u201320.","journal-title":"Nat Rev Microbiol"},{"key":"129_CR124","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69:881\u201391.","journal-title":"J Antimicrob Chemother"},{"key":"129_CR125","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1128\/AAC.02176-12","volume":"57","author":"KA Brown","year":"2013","unstructured":"Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57:2326\u201332.","journal-title":"Antimicrob Agents Chemother"},{"key":"129_CR126","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/nm.4174","volume":"22","author":"JP Zackular","year":"2016","unstructured":"Zackular JP, Moore JL, Jordan AT, Juttukonda LJ, Noto MJ, Nicholson MR, et al. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Nat Med. 2016;22:1330\u20134.","journal-title":"Nat Med"},{"key":"129_CR127","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41564-018-0150-6","volume":"3","author":"AJ Hryckowian","year":"2018","unstructured":"Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, et al. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model. Nat Microbiol. 2018;3:662\u20139.","journal-title":"Nat Microbiol"},{"key":"129_CR128","doi-asserted-by":"publisher","first-page":"e00708","DOI":"10.1128\/mSphere.00708-19","volume":"5","author":"MK Schnizlein","year":"2020","unstructured":"Schnizlein MK, Vendrov KC, Edwards SJ, Martens EC, Young VB. Dietary xanthan gum alters antibiotic efficacy against the murine gut microbiota and attenuates Clostridioides difficile colonization. mSphere. 2020;5:e00708\u201319.","journal-title":"mSphere"},{"key":"129_CR129","doi-asserted-by":"publisher","first-page":"eaam7019.","DOI":"10.1126\/scitranslmed.aam7019","volume":"10","author":"EJ Battaglioli","year":"2018","unstructured":"Battaglioli EJ, Hale VL, Chen J, Jeraldo P, Ruiz-Mojica C, Schmidt BA, et al. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea. Sci Transl Med. 2018;10:eaam7019.","journal-title":"Sci Transl Med"},{"key":"129_CR130","doi-asserted-by":"publisher","first-page":"e00765","DOI":"10.1128\/mSystems.00765-19","volume":"5","author":"CC Mefferd","year":"2020","unstructured":"Mefferd CC, Bhute SS, Phan JR, Villarama JV, Do DM, Alarcia S, et al. A high-fat\/high-protein, atkins-type diet exacerbates Clostridioides (Clostridium) difficile infection in mice, whereas a high-carbohydrate diet protects. mSystems. 2020;5:e00765\u201319.","journal-title":"mSystems"},{"key":"129_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2019.02.016","volume":"57","author":"DL Suskind","year":"2019","unstructured":"Suskind DL, Lee D, Solan P, Wahbeh G, Hayden H, Brittnacher M, et al. Dietary therapy for clostridium difficile colonization: a case series. Anaerobe. 2019;57:1\u20133.","journal-title":"Anaerobe."},{"key":"129_CR132","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4161\/gmic.1.1.10768","volume":"1","author":"GP Carter","year":"2010","unstructured":"Carter GP, Rood JI, Lyras D. The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes. 2010;1:58\u201364.","journal-title":"Gut Microbes"},{"key":"129_CR133","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1128\/IAI.00448-12","volume":"80","author":"I Jarchum","year":"2012","unstructured":"Jarchum I, Liu M, Shi C, Equinda M, Pamer EG. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun. 2012;80:2989\u201396.","journal-title":"Infect Immun"},{"key":"129_CR134","doi-asserted-by":"publisher","first-page":"e1002076","DOI":"10.1371\/journal.ppat.1002076","volume":"7","author":"A Ryan","year":"2011","unstructured":"Ryan A, Lynch M, Smith SM, Amu S, Nel HJ, McCoy CE, et al. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog. 2011;7:e1002076.","journal-title":"PLoS Pathog"},{"key":"129_CR135","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.4049\/jimmunol.1003761","volume":"186","author":"M Hasegawa","year":"2011","unstructured":"Hasegawa M, Yamazaki T, Kamada N, Tawaratsumida K, Kim YG, Nunez G, et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol. 2011;186:4872\u201380.","journal-title":"J Immunol"},{"key":"129_CR136","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/imm.12414","volume":"144","author":"AA Sadighi Akha","year":"2015","unstructured":"Sadighi Akha AA, McDermott AJ, Theriot CM, Carlson PE Jr., Frank CR, McDonald RA, et al. Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice. Immunology. 2015;144:587\u201397.","journal-title":"Immunology."},{"key":"129_CR137","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.chom.2015.06.011","volume":"18","author":"MC Abt","year":"2015","unstructured":"Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Susac B, et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe. 2015;18:27\u201337.","journal-title":"Cell Host Microbe"},{"key":"129_CR138","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.celrep.2016.06.007","volume":"16","author":"EL Buonomo","year":"2016","unstructured":"Buonomo EL, Cowardin CA, Wilson MG, Saleh MM, Pramoonjago P, Petri WA Jr. Microbiota-regulated IL-25 increases eosinophil number to provide protection during Clostridium difficile infection. Cell Rep. 2016;16:432\u201343.","journal-title":"Cell Rep"},{"key":"129_CR139","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"FA Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302\u20137.","journal-title":"Clin Infect Dis"},{"key":"129_CR140","doi-asserted-by":"publisher","first-page":"465","DOI":"10.14740\/jocmr3854","volume":"11","author":"T Singh","year":"2019","unstructured":"Singh T, Bedi P, Bumrah K, Singh J, Rai M, Seelam S. Updates in treatment of recurrent Clostridium difficile infection. J Clin Med Res. 2019;11:465\u201371.","journal-title":"J Clin Med Res"},{"key":"129_CR141","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/gut.49.1.152","volume":"49","author":"L Kyne","year":"2001","unstructured":"Kyne L, Kelly CP. Recurrent Clostridium difficile diarrhoea. Gut. 2001;49:152\u20133.","journal-title":"Gut."},{"key":"129_CR142","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407\u201315.","journal-title":"N Engl J Med"},{"key":"129_CR143","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","volume":"156","author":"CL Hvas","year":"2019","unstructured":"Hvas CL, Dahl Jorgensen SM, Jorgensen SP, Storgaard M, Lemming L, Hansen MM, et al. Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection. Gastroenterology. 2019;156:1324\u201332. e3","journal-title":"Gastroenterology."},{"key":"129_CR144","doi-asserted-by":"publisher","first-page":"e000087","DOI":"10.1136\/bmjgast-2016-000087","volume":"3","author":"H Sbahi","year":"2016","unstructured":"Sbahi H, Di Palma JA. Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol. 2016;3:e000087.","journal-title":"BMJ Open Gastroenterol"},{"key":"129_CR145","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature12503","volume":"502","author":"KM Ng","year":"2013","unstructured":"Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 2013;502:96\u20139.","journal-title":"Nature."},{"key":"129_CR146","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41591-020-0764-0","volume":"26","author":"H Nagao-Kitamoto","year":"2020","unstructured":"Nagao-Kitamoto H, Leslie JL, Kitamoto S, Jin C, Thomsson KA, Gillilland MG 3rd, et al. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat Med. 2020;26:608\u201317.","journal-title":"Nat Med"},{"key":"129_CR147","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15:111\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"129_CR148","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1128\/JB.00610-10","volume":"192","author":"JA Sorg","year":"2010","unstructured":"Sorg JA, Sonenshein AL. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol. 2010;192:4983\u201390.","journal-title":"J Bacteriol"},{"key":"129_CR149","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1136\/gutjnl-2018-317842","volume":"68","author":"BH Mullish","year":"2019","unstructured":"Mullish BH, McDonald JAK, Pechlivanis A, Allegretti JR, Kao D, Barker GF, et al. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection. Gut. 2019;68:1791\u2013800.","journal-title":"Gut."},{"key":"129_CR150","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015;517:205\u20138.","journal-title":"Nature"},{"key":"129_CR151","doi-asserted-by":"publisher","first-page":"e1002995","DOI":"10.1371\/journal.ppat.1002995","volume":"8","author":"TD Lawley","year":"2012","unstructured":"Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012;8:e1002995.","journal-title":"PLoS Pathog"},{"key":"129_CR152","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmi.2014.07.003","volume":"21","author":"M Tvede","year":"2015","unstructured":"Tvede M, Tinggaard M, Helms M. Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000\u20132012. Clin Microbiol Infect. 2015;21:48\u201353.","journal-title":"Clin Microbiol Infect"},{"key":"129_CR153","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1172\/JCI43918","volume":"120","author":"C Ubeda","year":"2010","unstructured":"Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120:4332\u201341.","journal-title":"J Clin Invest"},{"key":"129_CR154","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","volume":"174","author":"N Zmora","year":"2018","unstructured":"Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174:1388\u2013405. e21","journal-title":"Cell."},{"key":"129_CR155","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole PW, Marchesi JR, Hill C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. 2017;2:17057.","journal-title":"Nat Microbiol"},{"key":"129_CR156","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, Backhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19:77\u201394.","journal-title":"Nat Rev Microbiol"},{"key":"129_CR157","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332\u201345.","journal-title":"Cell."},{"key":"129_CR158","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1099\/mic.0.068767-0","volume":"160","author":"MC Rea","year":"2014","unstructured":"Rea MC, Alemayehu D, Casey PG, O\u2019Connor PM, Lawlor PG, Walsh M, et al. Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract. Microbiology (Reading). 2014;160:439\u201345.","journal-title":"Microbiology (Reading)"},{"key":"129_CR159","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki K, Deehan EC, Walter J, Backhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23:705\u201315.","journal-title":"Cell Host Microbe"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41435-021-00129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-021-00129-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-021-00129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:30:22Z","timestamp":1675233022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-021-00129-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":159,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1038\/s41435-021-00129-5","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}